| 1 |
VanDyke D, Taylor JD, Kaeo KJ, Hunt J, Spangler JB. Biologics-based degraders - an expanding toolkit for targeted-protein degradation. Curr Opin Biotechnol 2022;78:102807. [PMID: 36179405 DOI: 10.1016/j.copbio.2022.102807] [Reference Citation Analysis]
|
| 2 |
Békés M, Langley DR, Crews CM. PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov 2022;21:181-200. [PMID: 35042991 DOI: 10.1038/s41573-021-00371-6] [Cited by in Crossref: 268] [Cited by in F6Publishing: 249] [Article Influence: 268.0] [Reference Citation Analysis]
|
| 3 |
Wang WH, Yuan T, Qian MJ, Yan FJ, Yang L, He QJ, Yang B, Lu JJ, Zhu H. Post-translational modification of KRAS: potential targets for cancer therapy. Acta Pharmacol Sin 2021;42:1201-11. [PMID: 33087838 DOI: 10.1038/s41401-020-00542-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 4 |
Zhang Y, Chen Y, Li Y, Huang F, Luo B, Yuan Y, Xia B, Ma X, Yang T, Yu F, Liu J, Liu B, Song Z, Chen J, Yan S, Wu L, Pan T, Zhang X, Li R, Huang W, He X, Xiao F, Zhang J, Zhang H. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι. Proc Natl Acad Sci U S A 2021;118:e2024202118. [PMID: 34021074 DOI: 10.1073/pnas.2024202118] [Cited by in Crossref: 116] [Cited by in F6Publishing: 163] [Article Influence: 58.0] [Reference Citation Analysis]
|
| 5 |
Lim S, Khoo R, Juang YC, Gopal P, Zhang H, Yeo C, Peh KM, Teo J, Ng S, Henry B, Partridge AW. Exquisitely Specific anti-KRAS Biodegraders Inform on the Cellular Prevalence of Nucleotide-Loaded States. ACS Cent Sci 2021;7:274-91. [PMID: 33655066 DOI: 10.1021/acscentsci.0c01337] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 6 |
Lim S, Khoo R, Juang Y, Gopal P, Zhang H, Yeo C, Peh KM, Teo J, Ng S, Henry B, Partridge AW. bioPROTACs establish RAS as a degradable target and provide novel RAS biology insights.. [DOI: 10.1101/2020.06.26.174565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 7 |
Slastnikova TA, Ulasov AV, Rosenkranz AA, Sobolev AS. Targeted Intracellular Delivery of Antibodies: The State of the Art. Front Pharmacol 2018;9:1208. [PMID: 30405420 DOI: 10.3389/fphar.2018.01208] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 20.4] [Reference Citation Analysis]
|
